It is indicated that the product is not returning for evaluation.Since the product associated with the complaint was not returned, a review of in-house testing was performed.Retain strip testing results met both accuracy and strip repeatability criteria.The product performed as expected and no product deficiencies were observed.A review of the manufacturing records for the lot did not uncover any relevant non-conformances.The lot meets release specification.Root cause is unable to be determined from the information provided.Based on the information available, there is no indication of a product deficiency.No corrective action is required at this time.
|
Patient self tester's mother (b)(6) called in with an alleged precision issue while testing her son's inr with inratio.The patient self tester's mother does the testing and the nurse adjusts the coumadin dose depending on the inr result.Results were as follows: (b)(6): inratio=1.5, coumadin increased from 8 mg/day to alternating 8 mg/day with 9 mg/day.(b)(6): inratio=2.3, thus remained at the alternating dosing schedule.(b)(6): inratio=3.2, bruising, which stated "did not appear to be spontaneous, he may have fallen"; so dropped coumadin back down to 8 mg/day.(b)(6): inratio=2.6.(b)(6): inratio=1.2, 14 hours later increased the coumadin dose to 9mg.(b)(6): called tech service dept; while on the phone she retested him and got an inr=3.1.No bruising observed.Intends to resume 8 mg and will consult with physician.Patient self tester's therapeutic range is: 2-3.
|